قالب وردپرس درنا توس
Home / Health / Recall for blood pressure medicines: losartan, valsartan, amlopidine

Recall for blood pressure medicines: losartan, valsartan, amlopidine



If it looks like there's been a lot of blood pressure medication, well, that's because the United States Food and Drug Administration (FDA) has been following the voluntary recall of blood pressure medicines, Fortune ,

Among the high blood pressure medicines consumers need to know are losartan, valsartan, amlopidine, irbesartan and hydrochlorothiazide.

Meanwhile, the list has grown to more than half a dozen types of high blood pressure medicines under FDA recall. The cause of all these blood pressure medicines is the same: contamination of one of the two organic chemicals N-nitrosodimethylamine (NDMA) and N-nitrosodiethylamine (NDEA), both of which are classified as likely human carcinogens. NDMA is a byproduct of industrial processing. NDEA is used for the production of liquid rocket fuel and is also a by-product of fish processing and pesticide production.

Since July, the FDA has been calling for consumers to consult their doctor before giving the tablets, even if their blood pressure medicines are part of this ongoing, massive recall for concern over the cancer-causing chemical that is present in all of these drugs Quantities occurs. However, discontinuing the use of high blood pressure medicines can have serious consequences and should only be done under medical supervision. Here are the names of the blood pressure medicines under FDA recall and more on each recall.

Losartan

For Sandoz Inc.'s Losartan Potassium Hydrochlorothiazide 1

00-milligram / 25-milligram tablets is a single-use recall in lot number JB8912. The pills were distributed after October 8, 2018 and have an expiration date of 06/2020.

Valsartan, amlodipine, hydrochlorothiazide

There have been numerous recalls for high blood pressure medicines containing valsartan, an adjunct used in generic medicines for the treatment of high blood pressure.

Companies such as Major Pharmaceuticals, Solco Healthcare and Teva Pharmaceuticals have withdrawn many medicines containing valsartan, and Teva has now recalled all unexpired valsartan-containing products in the US market, including amlodipine valsartan and amlodipine valsartan hydrochlorothiazide -Kombinationstabletten.

Irbesartan

Irbesartan doses of 75 mg, 150 mg and 300 mg were obtained from ScieGen Pharmaceuticals Inc. in early November. Irbesartan tablets are packaged in 30- and 90-tooth bottles and labeled as Westminster Pharmaceuticals and Golden State Medical Supply, Inc.


Source link